In addition, interactions between IL18, which is an immunity-enhancing cytokine, and IL18BP at the cell surface result in anti-tumor effects, including stimulation of T cell proliferation and increases in natural killer cell activity [29]. The gene discussed is IL18BP; the disease is neoplasm.